Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01979575 · ClinicalTrials.gov registry record
Trendelenburg Study
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 30
- Enrollment target
NCT01979575: Completed study, sponsored by University of California, Davis.
NCT01979575 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01979575 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
1\) Observe the hemodynamic and cardiovascular changes associated with the change from the supine to the steep Trendelenburg position, 2) Observe the hemodynamic and cardiovascular changes during intra-abdominal insufflation used during laparoscopic surgical procedures.
Primary Outcome
Changes in cardiac output associated with patient position.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-07 |
What the finished NCT01979575 record still lists
NCT01979575 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01979575 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01979575 about?
NCT01979575 is a clinical study titled "Trendelenburg Study". 1\) Observe the hemodynamic and cardiovascular changes associated with the change from the supine to the steep Trendelenburg position, 2) Observe the hemodynamic and cardiovascular changes during intra-abdominal insufflation used during laparoscopic surgical procedures.
What is the current status of trial NCT01979575?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2013-10. Estimated completion is 2015-07.
Who is sponsoring clinical trial NCT01979575?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia